Artificial Intelligence in Pharma: Help or Risk?
Today we will tell you about another new feature of the exhibition's business program - a session dedicated to the use of AI in the pharmaceutical industry.
With just over two months left until the Pharmtech&Ingredients exhibition, the business program continues to unfold!
And again about the new product!
One of the most pressing issues in the pharmaceutical industry today is the implementation of artificial intelligence (AI) technologies in production. The use of such technologies is now becoming not only an anchor for optimization but also an indicator of competitiveness. On the other hand, it requires a comprehensive review of processes, and companies are increasingly faced with a certain degree of digital immaturity, a lack of competencies, and high risks.
What we'll talk about:
During this session, we will discuss how artificial intelligence is already transforming the industry, address data security issues, and identify which competencies the industry needs to develop today.
Key topics of the session: • AI in the development of new drugs: data preparation for modeling, interpretation of results and their correctness, copyright • AI and quality control: optimization and continuous monitoring of results, responsibility, safety and security of data • Strategy and competencies: vulnerability to attacks, purity and reliability of data, development of competencies for working with AI
In the first part, the speakers will share their views on the challenges of implementing AI in the pharmaceutical industry, and in the second part, we invite the audience to ask practical questions of our speakers and become part of an engaging discussion.
The session will be held with the support of the closed IT and IS club for pharmaceutical industry leaders, PHARMACOD , and will be moderated by the club's founder, Pavel Karasev.
You can view the business program schedule and download a short version below: